All the Active Ingredient Drugs
Hematinic. Iron (as Iron (III) Hydroxide Polymaltose Complex) 100 mg, Folic Acid 0.4 mg. TABS: 30. Manifest iron defic: 1 tab 2-3
x dly until hem. value normal. Maint: 1
tab dly. Latent iron defic. and prevent.
iron and folic acid defic: 1 tab dly.
Prevent. and tmt. anem. caused by iron
and folic acid defic.
Hematinic. Iron (as Iron (III) Hydroxide Polymaltose Complex) 50 mg. SYR: 110 ml. Anem: Adults and child
over 12 yrs old, and nursing mothers:
10-20 ml dly; Pregn. women: 20 ml dly;
Child 2-12 yrs: Up to 6 mg (0.6 ml)/kg
bdy wt. dly. Proph: Over 12 yrs and
pregn. women: 5-10 ml dly. Child 1-12
yrs: 1 mg (0.1 ml)/kg bdy wt. dly; Babies
under 2 yrs: Not more than 15 mg dly
for proph. ther.
Prevent. and tmt. anem. due to latent,
manifest iron defic.
C/I: Iron overload, anem. not due to iron
Hematinic. Iron (as sodium ferric gluconate complex) 62.5 mg / 5 ml. AMPS: 5 x 5 ml.
Single or dly doses by slow I.V. inject.
Dly dose for adults: 3.2 ml/5 ml
depend. on amt. iron defic. See lit.
Adult., child. 6 yrs. and above. Severe iron
defic. when oral admin. impossible,
gastrointest. malabsorpt., dialysis pts.
C/I: Hypersens. to the product; Known
serious hypersens. to other parenteral
iron product.; Iron overload
haemolysis) or iron utilisation disorders
(sideroblastic anaemia, lead anaemia,
thalassaemia), Sev. inflamm. dis. of the
liver or kidneys; premature babies or
neonates, due to the content of benzyl
alcohol; hereditary fructose intolerance,
glucose-galactose malabsorption or